Publications by authors named "DS Robertson"

Claim this Profile
R
Revolutionizing IBD Clinical Trials with Bayesian Approaches.
Nurulamin M Noor, Haiyan Zheng, David S Robertson, Siddharth Singh

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease.
Daniel Wolff, Corey Cutler, Iveta Mercep, Thomas Jaki, David S Robertson

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomization in the age of platform trials: unexplored challenges and some potential solutions.
Olga Kuznetsova, Jennifer Ross, Daniel Bodden, Freda Cooner, Jonathan Chipman, David S Robertson

BMC Med Res Methodol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trials.
Helen Mossop, Zoë Walmsley, Nina Wilson, Opeyemi Agbeleye, Michelle Bardgett, David S Robertson

BMC Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.
David S Robertson, Thomas Burnett, Babak Choodari-Oskooei, Munya Dimairo, Michael Grayling

Stat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance.
David S Robertson, Thomas Burnett, Babak Choodari-Oskooei, Munya Dimairo, Michael Grayling

Stat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis.
Athimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, Gianmarco Caruso, David S Robertson

Pediatr Rheumatol Online J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting results from biomarker-guided clinical trials: avoiding "negative" or "failed" terminology.
Nurulamin M Noor, Haiyan Zheng, David S Robertson, Joshua Savage, Christina Yap

BMC Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.
Scott D Newsome, Lawrence Goldstick, Derrick S Robertson, James D Bowen, Robert T Naismith

Ann Clin Transl Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How could a pooled testing policy have performed in managing the early stages of the COVID-19 pandemic? Results from a simulation study.
Bethany Heath, Sofía S Villar, David S Robertson

Stat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating pooled testing for asymptomatic screening of healthcare workers in hospitals.
Bethany Heath, Stephanie Evans, David S Robertson, Julie V Robotham, Sofía S Villar

BMC Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing.
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, David S Robertson

Trials· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online multiple hypothesis testing.
David S Robertson, James M S Wason, Aaditya Ramdas

Stat Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing.
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, David S Robertson

Trials· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online error rate control for platform trials.
David S Robertson, James M S Wason, Franz König, Martin Posch, Thomas Jaki

Stat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point estimation for adaptive trial designs II: Practical considerations and guidance.
David S Robertson, Babak Choodari-Oskooei, Munya Dimairo, Laura Flight, Philip Pallmann

Stat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familywise error rate control for block response-adaptive randomization.
Ekkehard Glimm, David S Robertson

Stat Methods Med Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Biochemistry and Biophysics of Living Cell Formation.
D S Robertson

Cell Biochem Biophys· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adaptive randomization in clinical trials: from myths to practical considerations.
David S Robertson, Kim May Lee, Boryana C López-Kolkovska, Sofía S Villar

Stat Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global FDR control across multiple RNAseq experiments.
Lathan Liou, Milena Hornburg, David S Robertson

Bioinformatics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point estimation for adaptive trial designs I: A methodological review.
David S Robertson, Babak Choodari-Oskooei, Munya Dimairo, Laura Flight, Philip Pallmann

Stat Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefits of covariate adjustment for adaptive multi-arm designs.
Kim May Lee, David S Robertson, Thomas Jaki, Richard Emsley

Stat Methods Med Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some performance considerations when using multi-armed bandit algorithms in the presence of missing data.
Xijin Chen, Kim May Lee, Sofia S Villar, David S Robertson

PLoS One· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.
Kevin Kunzmann, Michael J Grayling, Kim May Lee, David S Robertson, Kaspar Rufibach

Stat Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials.
Kevin Kunzmann, Michael J Grayling, Kim May Lee, David S Robertson, Kaspar Rufibach

Am Stat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis